Developing a vaccine for type 1 diabetes by targeting coxsackievirus B

References

• Pociot F, Akolkar B, Concannon P, et al. Genetics of type 1 diabetes: what’s next? Diabetes. 2010;59:1561–1571.
   PubMed Web of Science ®Google Scholar
• Knip M, Veijola R, Virtanen SM, et al. Environmental triggers and determinants of type 1 diabetes. Diabetes. 2005;54(Suppl 2):S125–S136.
   PubMedGoogle Scholar
• Hyöty H. Viruses in type 1 diabetes. Pediatr Diabetes. 2016;17(Suppl 22):56–64.
   PubMed Web of Science ®Google Scholar
• Insel RA, Dunne JL, Atkinson MA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the endocrine society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964–1974.
   PubMed Web of Science ®Google Scholar
• Hyöty H, Taylor KW. The role of viruses in human diabetes. Diabetologia. 2002;45(10):1353–1361.
   PubMed Web of Science ®Google Scholar
• Yoon JW, Jun HS. Viruses cause type 1 diabetes in animals. Ann NY Acad Sci. 2006;1079:138–146.
   PubMed Web of Science ®Google Scholar
• Rasmussen T, Witsø E, Tapia G, et al. Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: the MIDIA study. Diabetes Metab Res Rev. 2011;7:834–837.
   Google Scholar
• Beyerlein A, Wehweck F, Ziegler AG, et al. Respiratory infections in early life and the development of islet autoimmunity in children at increased type 1 diabetes risk: evidence from the BABYDIET study. JAMA Pediatr. 2013;167:800–807.
   PubMed Web of Science ®Google Scholar
• Lönnrot M, Lynch KF, Elding Larsson H, et al. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study. Diabetologia. 2017;60(10):1931–1940.
   PubMed Web of Science ®Google Scholar
• Mustonen N, Siljander H, Peet A, et al. Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk. Pediatr Diabetes. 2018;19:293–299.
   PubMed Web of Science ®Google Scholar
• Hyöty H, Knip M. Developing a vaccine for type 1 diabetes through targeting enteroviral infections. Expert Rev Vaccines. 2014;13(8):989–999.
   PubMed Web of Science ®Google Scholar
• Hober D, Alidjinou EK. Enteroviral pathogenesis of type 1 diabetes: queries and answers. Curr Opin Infect Dis. 2013;26(3):263–269.
   PubMed Web of Science ®Google Scholar
• Jenson AB, Rosenberg HS, Notkins AL. Pancreatic islet-cell damage in children with fatal viral infections. Lancet. 1980;2:354–358.
   PubMed Web of Science ®Google Scholar
• Racaniello VR. One hundred years of poliovirus pathogenesis. Virology. 2006;344(1):9–16.
   PubMed Web of Science ®Google Scholar
• Chapman NM, Kim KS. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol. 2008;323:275–292.
   PubMed Web of Science ®Google Scholar
• Yajima T. Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection. Future Microbiol. 2011;6(5):551–566.
   PubMed Web of Science ®Google Scholar
• Tam PE, Schmidt AM, Ytterberg SR, et al. Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis. J Lab Clin Med. 1994;123:346–356.
   PubMed Web of Science ®Google Scholar
• Feuer R, Ruller CM, An N, et al. Viral persistence and chronic immunopathology in the adult central nervous system following coxsackievirus infection during the neonatal period. J Virol. 2009;83:9356–9369.
   PubMed Web of Science ®Google Scholar
• MacLennan C, Dunn G, Huissoon AP, et al. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet. 2004;363(9420):1509–1513.
   PubMed Web of Science ®Google Scholar
• Kim KS, Tracy S, Tapprich W, et al. 5ʹ-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J Virol. 2005;79(11):7024–7041.
   PubMed Web of Science ®Google Scholar
• Mueller S, Wimmer E, Cello J. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. Virus Res. 2005;111:175–193.
   PubMed Web of Science ®Google Scholar
• Ida-Hosonuma M1, Iwasaki T, Yoshikawa T, et al. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol. 2005;79:4460–4469.
   PubMed Web of Science ®Google Scholar
• Kaufman DL, Erlander MG, Clare-Salzler M, et al. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest. 1992;89(1):283–292.
   PubMed Web of Science ®Google Scholar
• Härkönen T, Paananen A, Lankinen H, et al. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans. J Med Virol. 2003;69(3):426–440.
   PubMed Web of Science ®Google Scholar
• Horwitz MS, Bradley LM, Harbertson J, et al. Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med. 1998;4(7):781–785.
   PubMed Web of Science ®Google Scholar
• Ylipaasto P, Klingel K, Lindberg AM, et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia. 2004;47:225–239.
   PubMed Web of Science ®Google Scholar
• Croft SN, Walker EJ, Ghildyal R. Picornaviruses and apoptosis: subversion of cell death. MBio. 2017;8(5):e01009–172.
   PubMed Web of Science ®Google Scholar
• Barboni E, Manocchio J. Alterazioni pancreatiche in bovini con diabete mellito post-aftoso. Arch Vet Ital. 1962;13:477–489.
   Google Scholar
• Jun HS, Kang Y, Notkins AL, et al. Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus. J Virol. 1997;71(12):9782–9785.
   PubMed Web of Science ®Google Scholar
• Jun HS, Yoon JW. The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia. 2001;44(3):271–285.
   PubMed Web of Science ®Google Scholar
• Jun HS, Yoon SW, Kang Y, et al. Cloning and expression of the VP1 major capsid protein of diabetogenic encephalomyocarditis (EMC) virus and prevention of EMC virus-induced diabetes by immunization with the recombinant VP1 protein. J Gen Virol. 1995;76:2557–2566.
   PubMed Web of Science ®Google Scholar
• Notkins AL, Yoon JW. Virus-induced diabetes in mice prevented by a live attenuated vaccine. N Engl J Med. 1982;306(8):486.
   PubMed Web of Science ®Google Scholar
• Toniolo A, Onodera T, Jordan G, et al. Virus-induced diabetes mellitus. Glucose abnormalities produced in mice by the six members of the coxsackie B virus group. Diabetes. 1982;31(6):496–499.
   PubMed Web of Science ®Google Scholar
• Jaidane H, Sane F, Gharbi J, et al. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab Res Rev. 2009;25:591–603.
   PubMed Web of Science ®Google Scholar
• Flodström M, Maday A, Balakrishna D, et al. Target cell defense prevents the development of diabetes after viral infection. Nat Immunol. 2002;3:373–382.
   PubMed Web of Science ®Google Scholar
• Tracy S, Drescher KM. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes. Ann NY Acad Sci. 2007;1103:143–151.
   PubMed Web of Science ®Google Scholar
• Yoon JW, London WT, Curfman BL, et al. Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes. 1986;35:712–716.
   PubMed Web of Science ®Google Scholar
• Anagandula M, Richardson SJ, Oberste MS, et al. Infection of human islets of langerhans with two strains of coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway. J Med Virol J Med Virol. 2014;86(8):1402–1411.
   PubMed Web of Science ®Google Scholar
• Hodik M, Lukinius A, Korsgren O, et al. Tropism analysis of two coxsackie B5 strains reveals irus growth in human primary pancreatic islets but not in exocrine cell clusters in vitro. Open Virol J. 2013;7:49–56.
   PubMedGoogle Scholar
• Izumi K, Mine K, Inoue Y, et al. Reduced Tyk2 gene expression in β-cells due to natural mutation determines susceptibility to virus-induced diabetes. Nat Commun. 2015;6:6748.
   PubMed Web of Science ®Google Scholar
• Hämäläinen S, Nurminen N, Ahlfors H, et al. Coxsackievirus B1 reveals strain specific differences in plasmacytoid dendritic cell mediated immunogenicity. J Med Virol. 2014;86:1412–1420.
   PubMed Web of Science ®Google Scholar
• Op de Beeck A, Dl E. Viral infections in type 1 diabetes mellitus – why the β cells? Nat Rev Endocrinol. 2016;12:263–273.
   PubMed Web of Science ®Google Scholar
• Sane F, Caloone D, Gmyr V, et al. Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates. Cell Mol Life Sci. 2013;70:4169–4180.
   PubMed Web of Science ®Google Scholar
• Bissel SJ, Winkler CC, Deltondo J, et al. Coxsackievirus B4 myocarditis and meningoencephalitis in newborn twins. Neuropathology. 2014;34:429–437.
   PubMed Web of Science ®Google Scholar
• Richardson SJ, Willcox A, Bone AJ, et al. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia. 2009;52:1143–1151.
   PubMed Web of Science ®Google Scholar
• Richardson SJ, Leete P, Dhayal S, et al. Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia. 2014;57(2):392–401.
   PubMed Web of Science ®Google Scholar
• Krogvold L, Edwin B, Buanes T, et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes. 2015;64(5):1682–1687.
   PubMed Web of Science ®Google Scholar
• Krogvold L, Edwin B, Buanes T, et al. Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia. 2014;57(4):841–843.
   PubMed Web of Science ®Google Scholar
• Foulis AK, McGill M, Farquharson MA, et al. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia. 1997;40(1):53–61.
   PubMed Web of Science ®Google Scholar
• Yoon JW, Austin M, Onodera T, et al. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med. 1979;300:1173–1179.
   PubMed Web of Science ®Google Scholar
• Dotta F, Censini S, van Halteren AG, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl. Acad. Sci. USA. 2007;104:5115–5120.
   PubMed Web of Science ®Google Scholar
• Oikarinen M, Tauriainen S, Honkanen T, et al. Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia. 2008;51:1796–1802.
   PubMed Web of Science ®Google Scholar
• Ifie E, Russell MA, Dhayal S, et al. Unexpected subcellular distribution of a specific isoform of the coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells. Diabetologia. 2018;61(11):2344–2355.
   PubMed Web of Science ®Google Scholar
• Richardson SJ, Leete P, Bone AJ, et al. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of mcl-1. Diabetologia. 2013;56(1):185–193.
   PubMed Web of Science ®Google Scholar
• Gamble DR, Taylor KW, Cumming H. Coxsackie viruses and diabetes mellitus. Br Med J. 1973;4:260–262.
   PubMed Web of Science ®Google Scholar
• Gamble DR, Kinsley ML, FitzGerald MG, et al. Viral antibodies in diabetes mellitus. Br Med J. 1969;3:627–630.
   PubMed Web of Science ®Google Scholar
• Green J, Casabonne D, Newton R Coxsackie B virus serology and type 1 diabetes mellitus: a systematic review of published case-control studies. Diabet Med. 2004;21, 507–514.
   PubMed Web of Science ®Google Scholar
• Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. Br Med J. 2011;342:d35.
   PubMed Web of Science ®Google Scholar
• Honkanen H, Oikarinen S, Nurminen N, et al. Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia. 2017;60(3):424–431.
   PubMed Web of Science ®Google Scholar
• Oikarinen S, Martiskainen M, Tauriainen S, et al. Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes. 2011;60(1):276–279.
   PubMed Web of Science ®Google Scholar
• Tapia G, Cinek O, Rasmussen T, et al. Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diabetes Care. 2011;34:151–155.
   PubMed Web of Science ®Google Scholar
• Simonen-Tikka ML, Pflueger M, Klemola P, et al. Human enterovirus infections in children at increased risk for type 1 diabetes: the babydiet study. Diabetologia. 2011;54(12):2995–3002.
   PubMed Web of Science ®Google Scholar
• Cinek O, Stene LC, Kramna L, et al. Enterovirus RNA in longitudinal blood samples and risk of islet autoimmunity in children with a high genetic risk of type 1 diabetes: the MIDIA study. Diabetologia. 2014;57(10):2193–2200.
   PubMed Web of Science ®Google Scholar
• Hyöty H, Hiltunen M, Knip M, et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood diabetes in Finland (DiMe) study group. Diabetes. 1995;44(6):652–657.
   PubMed Web of Science ®Google Scholar
• Hiltunen M, Hyöty H, Knip M, et al. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood diabetes in Finland (DiMe) study group. J Infect Dis. 1997;175(3):554–560.
   PubMed Web of Science ®Google Scholar
• Viskari HR, Roivainen M, Reunanen A, et al. Maternal first-trimester enterovirus infection and future risk of type 1 diabetes in the exposed fetus. Diabetes. 2002;51(8):2568–2571.
   PubMed Web of Science ®Google Scholar
• Viskari H, Knip M, Tauriainen S, et al. Maternal enterovirus infection as a risk factor for type 1 diabetes in the exposed offspring. Diabetes Care. 2012;35(6):1328–1332.
   PubMed Web of Science ®Google Scholar
• Allen DW, Kim KW, Rawlinson WD, et al. Maternal virus infections in pregnancy and type 1 diabetes in their offspring: systematic review and meta-analysis of observational studies. Rev Med Virol. 2018;28:e1974.
   PubMed Web of Science ®Google Scholar
• Oikarinen M, Tauriainen S, Oikarinen S, et al. Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes. 2012;61:687–691.
   PubMed Web of Science ®Google Scholar
• Mercalli A, Lampasona V, Klingel K, et al. No evidence of enteroviruses in the intestine of patients with type 1 diabetes. Diabetologia. 2012;55(9):2479–2488.
   PubMed Web of Science ®Google Scholar
• Sioofy-Khojine AB, Lehtonen J, Nurminen N, et al. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes. Diabetologia. 2018;61(5):1193–1202.
   PubMed Web of Science ®Google Scholar
• Viskari HR, Koskela P, Lonnrot M, et al. Can enterovirus infections explain the increasing incidence of type 1 diabetes? Diabetes Care. 2000;23:414–416.
   PubMed Web of Science ®Google Scholar
• Viskari H, Ludvigsson J, Uibo R, et al. Relationship between the incidence of type 1 diabetes and enterovirus infections in different European populations: results from the EPIVIR project. J Med Virol. 2004;72:610–617.
   PubMed Web of Science ®Google Scholar
• Viskari H, Ludvigsson J, Uibo R, et al. Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia. 2005;48:1280–1287.
   PubMed Web of Science ®Google Scholar
• Larsson PG, Lakshmikanth T, Svedin E, et al. Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice. Diabetologia. 2013;56:867–874.
   PubMed Web of Science ®Google Scholar
• Laitinen OH, Honkanen H. Pakkanen O et al. Coxsackievirus B1 is associated with the induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes. 2014;63:446–455.
   PubMed Web of Science ®Google Scholar
• Haller MJ, Schatz DA. The DIPP project: 20 years of discovery in type 1 diabetes. Pediatr Diabetes. 2016;17(Suppl 22):5–7.
   PubMedGoogle Scholar
• Oikarinen S, Tauriainen S, Hober D, et al. Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes. Diabetes. 2014;63:655–662.
   PubMed Web of Science ®Google Scholar
• Sioofy-Khojine A, Lehtonen J, Cuthbertson D, et al. Coxsackievirus B infections are associated with the initiation of islet autoimmunity – results from the TRIGR study. Annual meeting of the Network for Pancreatic Organ Donors (nPOD); 2017; Fort Lauderdale, Florida, US.
   Google Scholar
• Ponsonby AL, Pezic A, Cameron FJ, et al. Parental occupational social contact is associated with a reduced risk of incident pediatric type 1 diabetes: mediation through molecular enteroviral indices. PLoS One. 2018;13:e0193992.
   PubMed Web of Science ®Google Scholar
• Afonso G, Mallone R. Infectious triggers in type 1 diabetes: is there a case for epitope mimicry? Diabetes Obes Metab. 2013;15(Suppl 3):82–88.
   PubMedGoogle Scholar
• Petzold A, Solimena M, Knoch KP. Mechanisms of beta cell dysfunction associated with viral infection. Curr Diab Rep. 2015;15(10):73.
   PubMed Web of Science ®Google Scholar
• Cabrera-Rode E, Sarmiento L, Tiberti C, et al. Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16. Diabetologia. 2003;46:1348–1353.
   PubMed Web of Science ®Google Scholar
• Paananen A, Ylipaasto P, Rieder E, et al. Molecular and biological analysis of echovirus 9 strain isolated from a diabetic child. J Med Virol. 2003;69(4):529–537.
   PubMed Web of Science ®Google Scholar
• Williams CH, Oikarinen S, Tauriainen S, et al. Molecular analysis of an echovirus 3 strain isolated from an individual concurrently with appearance of islet cell and IA-2 autoantibodies. J Clin Microbiol. 2006;44(2):441–448.
   PubMed Web of Science ®Google Scholar
• Moore M, Kaplan MH, McPhee J, et al. Epidemiologic, clinical, and laboratory features of coxsackie B1-B5 infections in the United States, 1970-79. Public Health Rep. 1984;99(5):515–522.
   PubMed Web of Science ®Google Scholar
• Sadeharju K, Knip M, Hiltunen M, et al. The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens. Diabetologia. 2003;46(8):1100–1105.
   PubMed Web of Science ®Google Scholar
• Smyth DJ, Cooper JD, Bailey R, et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet. 2006;38:617–619.
   PubMed Web of Science ®Google Scholar
• Heinig M, Petretto E, Wallace C, et al. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature. 2010;467(7314):460–464.
   PubMed Web of Science ®Google Scholar
• Wang Y, Shaked I, Stanford SM, et al. The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity. 2013;39(1):111–122.
   PubMed Web of Science ®Google Scholar
• Gorman JA, Hundhausen C, Errett JS, et al. The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunity. Nat Immunol. 2017;18:744–752.
   PubMed Web of Science ®Google Scholar
• Onengut-Gumuscu S, Chen WM, Burren O, et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet. 2015;47(4):381–386.
   PubMed Web of Science ®Google Scholar
• Nagafuchi S, Kamada-Hibio Y, Hirakawa K, et al. TYK2 promoter variant and diabetes mellitus in the Japanese. EBioMedicine. 2015;2(7):744–749.
   PubMed Web of Science ®Google Scholar
• Staeva TP, Chatenoud L, Insel R, et al. Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials. Diabetes. 2013;62(1):9–17.
   PubMed Web of Science ®Google Scholar
• Donath MY, Hess C, Palmer E. What is the role of autoimmunity in type 1 diabetes? A clinical perspective. Diabetologia. 2014;57(4):653–655.
   PubMed Web of Science ®Google Scholar
• Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med. 2009;361(22):2143–2152.
   PubMed Web of Science ®Google Scholar
• Knip M, Åkerblom HK, Al Taji E, et al. Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes: the TRIGR randomized clinical trial. JAMA. 2018;319:38–48.
   PubMed Web of Science ®Google Scholar
• Skog O, Korsgren S, Melhus A, et al. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease. Curr Opin Endocrinol Diabetes Obes. 2013;20(2):118–123.
   PubMed Web of Science ®Google Scholar
• Campbell-Thompson ML, Atkinson MA, Butler AE, et al. The diagnosis of insulitis in human type 1 diabetes. Diabetologia. 2013;56(11):2541–2543.
   PubMed Web of Science ®Google Scholar
• In’t Veld P. Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets. 2011;3(4):131–138.
   PubMed Web of Science ®Google Scholar
• Thomassen YE. van ‘t Oever AG, van Oijen MG et al. Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals. PLoS One. 2013;8(12):e83374.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li JX, Jin PF, et al. Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine. Expert Rev Vaccines. 2016;15(7):803–813.
   PubMed Web of Science ®Google Scholar
• Modlin JF, Rotbart HA. Group B coxsackie disease in children. Curr Top Microbiol Immunol. 1997;223:53–80.
   PubMed Web of Science ®Google Scholar
• Tam PE. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol. 2006;19(2):133–146.
   PubMed Web of Science ®Google Scholar
• Huang HI, Shih SR. Neurotropic enterovirus infections in the central nervous system. Viruses. 2015;7(11):6051–6066.
   PubMed Web of Science ®Google Scholar
• Abedi GR, Watson JT, Pham H, et al. Enterovirus and human parechovirus surveillance – United States, 2009-2013. MMWR Morb Mortal Wkly Rep. 2015;64:940–943.
   PubMed Web of Science ®Google Scholar
• Larsson PG, Lakshmikanth T, Laitinen OH, et al. A preclinical study on the efficacy and safety of a new vaccine against coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models. Diabetologia. 2015;58(2):346–354.
   PubMed Web of Science ®Google Scholar
• Koho T, Koivunen MLR, Oikarinen S, et al. Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice. Antiviral Res. 2014;104:93–101.
   PubMed Web of Science ®Google Scholar
• Hankaniemi MM, Laitinen OH, Stone VM, et al. Optimized production and purification of coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model. Vaccine. 2017;35(30):3718–3725.
   PubMed Web of Science ®Google Scholar
• Stone VM, Hankaniemi MM, Svedin E, et al. A coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes. Diabetologia. 2018;61(2):476–481.
   PubMed Web of Science ®Google Scholar
• Fohlman J, Ilbäck NG, Friman G, et al. Vaccination of Balb/c mice against enteroviral mediated myocarditis. Vaccine. 1990;8(4):381–384.
   PubMed Web of Science ®Google Scholar
• Toniolo A, Falcone V, Bernasconi C, et al. DNA immunization of mice against the VP1 capsid protein of coxsackievirus B4. Scand J Immunol. 2002;56(5):448–455.
   PubMed Web of Science ®Google Scholar
• Dan M, Chantler JK. A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection. J Virol. 2005;79(14):9285–9295.
   PubMed Web of Science ®Google Scholar
• Kim JY, Jeon ES, Lim BK, et al. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge. Vaccine. 2005;23(14):1672–1679.
   PubMed Web of Science ®Google Scholar
• Lan J, Gao Z, Xiong H, et al. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination. Vaccine. 2011;29(40):6894–6902.
   PubMed Web of Science ®Google Scholar
• Coppieters KT1, Wiberg A, von Herrath MG. Viral infections and molecular mimicry in type 1 diabetes. APMIS. 2012;120(12):941–949.
   PubMed Web of Science ®Google Scholar
• Viskari H, Oikarinen S, Hoppu S, et al. Live attenuated enterovirus vaccine (OPV) is not associated with islet autoimmunity in children with genetic susceptibility to type 1 diabetes: prospective cohort study. Diabetologia. 2018;61(1):203–2092.
   PubMed Web of Science ®Google Scholar
• Ahmed SS, Schur PH, MacDonald NE, et al. 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun. 2014;50:1–11.
   PubMed Web of Science ®Google Scholar